A new study, published in the The British Journal of Clinical Pharmacology, examined whether the use of epilepsy drug, lamotrigine, during pregnancy increased the risk of birth malformations or neurodevelopmental disorders.
Researchers studied the children of 83 epileptic women, who took lamotrigine during pregnancy between 2004 and 2014. They monitored the infants and gave the parents a questionnaire to complete regarding their child's development and health, up to the age of 12.
The study shows the children did not suffer from birth malformations or neurodevelopmental disorders.